Analysis of the upstream regulators of these candidate genes indicated that the TGFβ (SMAD3) and p53 (CDKN2A) pathways are likely to be involved in mammary tumor susceptibility in response to LDIR (Figure 2G). This evidence concerns the gene SMAD3 and breast cancer.